Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 3/20 | 0.64 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.51 |
| ▸ | CCR3 | P51677 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7458584 | 0.95 | CCR5 (0.65) | CCR5OPRM1CCR3SIGMAR1CYP2D6 | |
| SCHEMBL7456733 | 0.92 | CCR5 (0.66) | CCR5OPRM1 | |
| SCHEMBL3037256 | 0.91 | CCR5 (0.66) | CCR5OPRM1 | |
| SCHEMBL7458135 | 0.91 | CCR5 (0.57) | CCR5OPRM1 | |
| Hydrochloric Acid SCHEMBL7465772 | 0.90 | CCR5 (0.70) | CCR5OPRM1 | |
| SCHEMBL7458912 | 0.90 | CCR5 (0.62) | CCR5OPRM1CYP2D6GAA | |
| SCHEMBL7467086 | 0.89 | CCR5 (0.63) | CCR5OPRM1CCR3 | |
| SCHEMBL3032771 | 0.88 | CCR5 (0.62) | CCR5OPRM1 | |
| SCHEMBL7465873 | 0.88 | CCR5 (0.62) | CCR5OPRM1 | |
| SCHEMBL7463797 | 0.88 | CCR5 (0.62) | CCR5OPRM1CYP2D6SMAD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1180513-A1 | CYCLIC AMIDE COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2002-02-20 | — | — | EP | disclosed |